A Randomized, Double Blind, Parallel Group, Stratified, Multicenter, 12-Week Safety and Efficacy Study of an Investigational Budesonide HFA Metered Dose Inhaler and a Conventional Budesonide CFC Metered Dose Inhaler (Pulmicort) in Pediatric Patients with Asthma.
Study identifier:D5252C00003
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
A Randomized, Double Blind, Parallel Group, Stratified, Multicenter, 12-Week Safety and Efficacy Study of an Investigational Budesonide HFA Metered Dose Inhaler and a Conventional Budesonide CFC Metered Dose Inhaler (Pulmicort) in Pediatric Patients with Asthma.
Medical condition
asthma
Phase
Phase 3
Healthy volunteers
-
Study drug
-
Sex
-
Actual Enrollment
-
Study type
Interventional
Age
-
Date
Study Start Date: 01 Oct 2003
Primary Completion Date: -
Study Completion Date: -
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Nov 2013 by AstraZeneca
Sponsors
AstraZeneca
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|
